| Product Code: ETC13203168 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Choroidal Neovascularization Market was valued at USD 4.2 Billion in 2024 and is expected to reach USD 6 Billion by 2031, growing at a compound annual growth rate of 5.00% during the forecast period (2025-2031).
The global choroidal neovascularization (CNV) market is driven by factors such as the increasing prevalence of age-related macular degeneration (AMD), which is a leading cause of CNV. The market is characterized by the growing adoption of anti-VEGF (vascular endothelial growth factor) drugs for the treatment of CNV, as well as advancements in diagnostic technologies for early detection. Key players in the market are focusing on developing innovative therapies and targeted treatment approaches to improve patient outcomes. Geographically, North America holds a significant share in the CNV market due to the presence of well-established healthcare infrastructure and high awareness about retinal diseases. However, the Asia Pacific region is also witnessing rapid growth in the CNV market, driven by improving healthcare facilities and increasing investments in research and development.
The Global Choroidal Neovascularization Market is witnessing a significant shift towards the development of innovative treatment options such as anti-VEGF therapies and sustained-release drug delivery systems. These advancements are driving the market growth by offering improved efficacy and safety profiles for patients. Additionally, the increasing prevalence of age-related macular degeneration, diabetic retinopathy, and other eye disorders is expanding the patient pool for choroidal neovascularization treatments. Furthermore, the rising geriatric population globally, especially in developed economies, is creating a substantial market opportunity for companies operating in this space. Personalized medicine approaches and ongoing research in gene therapy are also expected to shape the future landscape of the market, providing further growth prospects for stakeholders.
The Global Choroidal Neovascularization Market faces several challenges, including limited treatment options, high cost of therapy, and the need for frequent monitoring and follow-up visits. The complex nature of the disease and the variability in patient response to existing treatments present obstacles for both healthcare providers and patients. Additionally, the competitive landscape with a few dominant players in the market can limit innovation and access to new therapies. Regulatory hurdles, such as lengthy approval processes for new drugs, also contribute to the challenges faced by companies operating in this market. Overall, addressing these challenges will require collaboration among stakeholders, increased research and development efforts, and a focus on improving patient outcomes while managing costs effectively.
The Global Choroidal Neovascularization Market is primarily driven by the increasing prevalence of age-related macular degeneration (AMD), which is a leading cause of choroidal neovascularization. The aging population, lifestyle changes leading to higher incidence of AMD risk factors such as smoking and poor diet, and the rising awareness about eye diseases and treatment options are key factors propelling market growth. Additionally, advancements in diagnostic technologies for early detection, development of innovative treatment options including anti-VEGF therapies and sustained-release drug delivery systems, and the increasing healthcare expenditure in emerging markets are further driving the market expansion. Moreover, collaborations between pharmaceutical companies, research institutions, and healthcare providers to develop novel therapies and improve patient outcomes are expected to contribute to the market`s growth trajectory.
Government policies related to the Global Choroidal Neovascularization Market primarily focus on promoting research and development in the field of ophthalmology, ensuring patient access to innovative treatments, and regulating the approval and commercialization of new therapies. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in evaluating the safety and efficacy of new drugs for choroidal neovascularization, ensuring compliance with quality standards, and monitoring post-market surveillance. Additionally, governments may provide funding or incentives to support clinical trials, encourage collaboration between industry and academia, and improve healthcare infrastructure for the early detection and management of this vision-threatening condition. Overall, government policies aim to drive innovation, protect patient safety, and enhance healthcare outcomes in the Global Choroidal Neovascularization Market.
The Global Choroidal Neovascularization Market is expected to experience steady growth in the coming years due to factors such as an aging population, increasing prevalence of age-related macular degeneration (AMD), and advancements in diagnostic and treatment options. The market is likely to be driven by the rising demand for innovative therapies, including anti-VEGF drugs and combination therapies. Additionally, the expanding healthcare infrastructure in emerging economies and growing awareness about eye health are anticipated to further boost market growth. However, challenges such as high treatment costs and limited access to care in some regions may hinder market expansion. Overall, the Global Choroidal Neovascularization Market is poised for growth, with opportunities for market players to develop novel treatments and expand their presence in untapped regions.
In the Global Choroidal Neovascularization Market, Asia is expected to witness significant growth due to the increasing prevalence of age-related macular degeneration in countries like Japan and China. North America is anticipated to lead the market, driven by the presence of advanced healthcare infrastructure and high awareness among the population. Europe is likely to follow closely behind, with a growing geriatric population and rising investments in research and development activities. The Middle East and Africa region is projected to show steady growth, attributed to improving access to healthcare services and rising healthcare expenditure. Latin America is also expected to contribute to market growth, driven by the increasing incidence of eye disorders and the adoption of advanced treatment options in countries like Brazil and Mexico.
Global Choroidal Neovascularization Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Choroidal Neovascularization Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Choroidal Neovascularization Market Revenues & Volume, 2021 & 2031F |
3.3 Global Choroidal Neovascularization Market - Industry Life Cycle |
3.4 Global Choroidal Neovascularization Market - Porter's Five Forces |
3.5 Global Choroidal Neovascularization Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Choroidal Neovascularization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Global Choroidal Neovascularization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Choroidal Neovascularization Market Revenues & Volume Share, By Type of Diagnosis, 2021 & 2031F |
3.9 Global Choroidal Neovascularization Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Global Choroidal Neovascularization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Choroidal Neovascularization Market Trends |
6 Global Choroidal Neovascularization Market, 2021 - 2031 |
6.1 Global Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Choroidal Neovascularization Market, Revenues & Volume, By Extreme Myopia, 2021 - 2031 |
6.1.3 Global Choroidal Neovascularization Market, Revenues & Volume, By Malignant Myopic Degeneration, 2021 - 2031 |
6.1.4 Global Choroidal Neovascularization Market, Revenues & Volume, By Age-Related Developments, 2021 - 2031 |
6.2 Global Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Choroidal Neovascularization Market, Revenues & Volume, By Extreme Myopia, 2021 - 2031 |
6.2.3 Global Choroidal Neovascularization Market, Revenues & Volume, By Malignant Myopic Degeneration, 2021 - 2031 |
6.2.4 Global Choroidal Neovascularization Market, Revenues & Volume, By Age-Related Developments, 2021 - 2031 |
6.3 Global Choroidal Neovascularization Market, Revenues & Volume, By Type of Diagnosis, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Choroidal Neovascularization Market, Revenues & Volume, By Fluorescein Angiography (FA), 2021 - 2031 |
6.3.3 Global Choroidal Neovascularization Market, Revenues & Volume, By Indocyanine Green (ICG) Angiography, 2021 - 2031 |
6.3.4 Global Choroidal Neovascularization Market, Revenues & Volume, By Spectral Domain Optical Coherence Tomography (OCT), 2021 - 2031 |
6.3.5 Global Choroidal Neovascularization Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Choroidal Neovascularization Market, Revenues & Volume, By Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Choroidal Neovascularization Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.4.3 Global Choroidal Neovascularization Market, Revenues & Volume, By Intravitreal, 2021 - 2031 |
7 North America Choroidal Neovascularization Market, Overview & Analysis |
7.1 North America Choroidal Neovascularization Market Revenues & Volume, 2021 - 2031 |
7.2 North America Choroidal Neovascularization Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Choroidal Neovascularization Market, Revenues & Volume, By Type of Diagnosis, 2021 - 2031 |
7.6 North America Choroidal Neovascularization Market, Revenues & Volume, By Type, 2021 - 2031 |
8 Latin America (LATAM) Choroidal Neovascularization Market, Overview & Analysis |
8.1 Latin America (LATAM) Choroidal Neovascularization Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Choroidal Neovascularization Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
8.4 Latin America (LATAM) Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Choroidal Neovascularization Market, Revenues & Volume, By Type of Diagnosis, 2021 - 2031 |
8.6 Latin America (LATAM) Choroidal Neovascularization Market, Revenues & Volume, By Type, 2021 - 2031 |
9 Asia Choroidal Neovascularization Market, Overview & Analysis |
9.1 Asia Choroidal Neovascularization Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Choroidal Neovascularization Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
9.4 Asia Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Choroidal Neovascularization Market, Revenues & Volume, By Type of Diagnosis, 2021 - 2031 |
9.6 Asia Choroidal Neovascularization Market, Revenues & Volume, By Type, 2021 - 2031 |
10 Africa Choroidal Neovascularization Market, Overview & Analysis |
10.1 Africa Choroidal Neovascularization Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Choroidal Neovascularization Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
10.4 Africa Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Choroidal Neovascularization Market, Revenues & Volume, By Type of Diagnosis, 2021 - 2031 |
10.6 Africa Choroidal Neovascularization Market, Revenues & Volume, By Type, 2021 - 2031 |
11 Europe Choroidal Neovascularization Market, Overview & Analysis |
11.1 Europe Choroidal Neovascularization Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Choroidal Neovascularization Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
11.4 Europe Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Choroidal Neovascularization Market, Revenues & Volume, By Type of Diagnosis, 2021 - 2031 |
11.6 Europe Choroidal Neovascularization Market, Revenues & Volume, By Type, 2021 - 2031 |
12 Middle East Choroidal Neovascularization Market, Overview & Analysis |
12.1 Middle East Choroidal Neovascularization Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Choroidal Neovascularization Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Choroidal Neovascularization Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
12.4 Middle East Choroidal Neovascularization Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Choroidal Neovascularization Market, Revenues & Volume, By Type of Diagnosis, 2021 - 2031 |
12.6 Middle East Choroidal Neovascularization Market, Revenues & Volume, By Type, 2021 - 2031 |
13 Global Choroidal Neovascularization Market Key Performance Indicators |
14 Global Choroidal Neovascularization Market - Export/Import By Countries Assessment |
15 Global Choroidal Neovascularization Market - Opportunity Assessment |
15.1 Global Choroidal Neovascularization Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Choroidal Neovascularization Market Opportunity Assessment, By Application, 2021 & 2031F |
15.3 Global Choroidal Neovascularization Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Choroidal Neovascularization Market Opportunity Assessment, By Type of Diagnosis, 2021 & 2031F |
15.5 Global Choroidal Neovascularization Market Opportunity Assessment, By Type, 2021 & 2031F |
16 Global Choroidal Neovascularization Market - Competitive Landscape |
16.1 Global Choroidal Neovascularization Market Revenue Share, By Companies, 2024 |
16.2 Global Choroidal Neovascularization Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here